People: Allergan Inc (AGN.N)

AGN.N on New York Stock Exchange

101.41USD
17 May 2013
Price Change (% chg)

$0.99 (+0.99%)
Prev Close
$100.42
Open
$100.59
Day's High
$101.43
Day's Low
$99.68
Volume
566,594
Avg. Vol
440,347
52-wk High
$116.44
52-wk Low
$81.28

Search Stocks

Endicott, David 

Brief Biography

Mr. David J. Endicott is Corporate Vice President and President - Allergan Medical, Asia Pacific and Latin America of Allergan Inc., since April 2011. He served as Corporate Vice President and President, Allergan Medical since August 2010. Prior to that, he served as Corporate Vice President and President, Europe, Africa and Middle East from October 2004 to August 2010 and managed the expansion of Allergan's business internationally, including Company's entry into new markets such as Turkey and Poland. Mr. Endicott served as Senior Vice President, U.S. Specialty Pharmaceuticals from January 2004 to October 2004, Vice President and General Manager of Canada from February 2000 to December 2003 and Vice President of U.S. Managed Markets since 1998. Prior to that, Mr. Endicott served various roles at Allergan since joining the Company in 1986. Mr. Endicott holds an undergraduate degree in Chemistry from Whitman College, an MBA from the University of Southern California and is a graduate of the Advanced Management Program at the Harvard Business School. Mr. Endicott serves on the board of directors of Orexigen Therapeutics, Inc., a publicly-traded company.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
838,100 -- 1,865,270 2,736,600

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised 82,000 2,756,330.00
Name Fiscal Year Total

David Pyott

21,164,200

Jeffrey Edwards

3,156,900

Scott Whitcup

3,570,090

Arnold Pinkston

--

Scott Sherman

--

Raymond Diradoorian

2,321,980
As Of 30 Dec 2012
Search Stocks